An improved orthotopic rat bladder tumor model using DiI-loaded fluorescent AY-27 cells

Cancer Biology and Therapy

Volumn 9, Issue 12, 2010, Pages 986-993

  Vandepitte, Joachim ^a   Maes, Jan ^a   Van Cleynenbreugel, Ben ^b   Van Poppel, Hein ^b   Lerut, Evelyne ^b   Agostinis, Patrizia ^b   De Witte, Peter A M ^a  

^a Faculteit Farmaceutische Wetenschappen   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

AY 27; Bladder cancer; DiI; Mitomycin c; Orthotopic animal model

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; MITOMYCIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER TUMOR; CANCER TRANSPLANTATION; CELL LABELING; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN AY 27; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; INOCULATION; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; RAT; SINGLE DRUG DOSE; TUMOR CELL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARBOCYANINES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENCE; FLUORESCENT DYES; MITOMYCIN; RATS; RATS, INBRED F344; STAINING AND LABELING; URINARY BLADDER NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77954415088     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.12.11638     Document Type: Article

References (32)

1. Kamat AM, Lamm DL. Chemoprevention of urological cancer. J Urol 1999; 161:1748-60.
2. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983; 130:1083-6. (Pubitemid 14207227)
3. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al. Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology International Consultation on Bladder Tumors 2005; 66:4-34.
4. Koya MP, Simon MA, Soloway MS. Complications of intravesical therapy for urothelial cancer of the bladder. J Urol 2006; 175:2004-10.
5. Kriegmair M, Waidelich R, Lumper W, Ehsan A, Baumgartner R, Hofstetter A. Integral photodynamic treatment of refractory superficial bladder cancer. J Urol 1995; 154:1339-41.
6. Berger AP, Steiner H, Stenzl A, Akkad T, Bartsch G, Holtl L. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study. Urology 2003; 61:338-41.
7. Kunze E, Schauer A, Schatt S. Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1976; 87:139-60.
8. Erturk E, Price JM, Morris JE, Cohen S, Leith RS, Von Esch AM, et al. The production of carcinoma of the urinary bladder in rats by feeding N-[3-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res 1967; 27:1998-2002.
9. Oliveira PA, Colaco A, De la Cruz PL, Lopes C. Experimental bladder carcinogenesis-rodent models. Exp Oncol 2006; 28:2-11.
10. Steinberg GD, Brendler CB, Ichikawa T, Squire RA, Isaacs JT. Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model. Cancer Res 1990; 50:6668-74. (Pubitemid 20348798)
11. Oldroyd RI, Poole RR, Reed RR, Lawson RK, Hodges CV. An animal model for the growth of human tumor cell lines. Invest Urol 1977; 14:434-9.
12. Oshinsky GS, Chen Y, Jarrett T, Anderson AE, Weiss GH. A model of bladder tumor xenografts in the nude rat. J Urol 1995; 154:1925-9.
13. Russell PJ, Raghavan D, Gregory P, Philips J, Wills EJ, Jelbart M, et al. Bladder cancer xenografts: a model of tumor cell heterogeneity. Cancer Res 1986; 46:2035-40. (Pubitemid 16117903)
14. Chong L, Ruping Y, Jiancheng B, Guohong Y, Yougang F, Jiansong W, et al. Characterization of a novel transplantable orthotopic murine xenograft model of a human bladder transitional cell tumor (BIU-87). Cancer Biol Ther 2006; 5:394-8.
15. Xiao Z, McCallum TJ, Brown KM, Miller GG, Halls SB, Parney I, et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer 1999; 81:638-46.
16. El Khatib S, Berrahmoune S, Leroux A, Bezdetnaya L, Guillemin F, D'Hallewin MA. A novel orthotopic bladder tumor model with predictable localization of a solitary tumor. Cancer Biol Ther 2006; 5:1327-31.
17. Bisson JF, Parache RM, Droulle P, Notter D, Vigneron C, Guillemin F. A new method of implanting orthotopic rat bladder tumor for experimental therapies. Int J Cancer 2002; 102:280-5.
18. Gant VA, Shakoor Z, Hamblin AS. A new method for measuring clustering in suspension between accessory cells and T lymphocytes. J Immunol Methods 1992; 156:179-89.
19. De Clerck LS, Bridts CH, Mertens AM, Moens MM, Stevens WJ. Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function. J Immunol Methods 1994; 172:115-24.
20. Honig MG, Hume RI. Fluorescent carbocyanine dyes allow living neurons of identified origin to be studied in long-term cultures. J Cell Biol 1986; 103:171-87.
21. Nygaard SJ, Pedersen PH, Mikkelsen T, Terzis AJ, Tysnes OB, Bjerkvig R. Glioma cell invasion visualized by scanning confocal laser microscopy in an in vitro coculture system. Invasion Metastasis 1995; 15:179-88. (Pubitemid 26290092)
22. Timmers M, Vermijlen D, Vekemans K, De Zanger R, Wisse E, Braet F. Tracing DiO-labelled tumour cells in liver sections by confocal laser scanning microscopy. J Microsc 2002; 208:65-74.
23. Hiscox S, Jiang WG. Quantification of tumour cell-endothelial cell attachment by 1,1′-dioctadecyl-3,3,3′,3′- tetramethylindocarbocyanine (DiI). Cancer Lett 1997; 112:209-17.
24. Ferrari A, Hannouche D, Oudina K, Bourguignon M, Meunier A, Sedel L, et al. In vivo tracking of bone marrow fibroblasts with fluorescent carbocyanine dye. J Biomed Mater Res 2001; 56:361-7.
25. Wishnow KI, Johnson DE, Grignon DJ, Cromeens DM, Ayala AG. Regeneration of the canine urinary bladder mucosa after complete surgical denudation. Urol 1989; 141:1476-9.
26. Bindels EM, Vermey M, Rebel JM, Zwarthoff EC, Van Der Kwast TH. In vitro modulation of implantation and intraepithelial expansion of bladder tumor cells by epidermal growth factor. Exp Cell Res 1997; 235:395-402.
27. Hendricksen K, Molkenboer-Kuenen J, Oosterwijk E, Hulsbergen-van de Kaa CA, Witjes JA. Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy. BJU Int 2008; 101:889-93.
28. Simamura E, Hirai KI, Shimada H, Koyama J. Apoptosis and epithelial phagocytosis in mitomycin C-treated human pulmonary adenocarcinoma A549 cells. Tissue Cell 2001; 33:161-8.
29. Barlogie B, Drewinko B. Lethal and cytokinetic effects of mitomycin C on cultured human colon cancer cells. Cancer Res 1980; 40:1973-80. (Pubitemid 10116123)
30. Nieto A, Cabrera CM, Catalina P, Cobo F, Barnie A, Cortes JL, et al. Effect of mitomycin-C on human foreskin fibroblasts used as feeders in human embryonic stem cells: immunocytochemistry MIB1 score and DNA ploidy and apoptosis evaluated by flow cytometry. Cell Biol Int 2007; 31:269-78.
31. Mostafid AH, Rajkumar RG, Stewart AB, Singh R. Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer. BJU Int 2006; 97:509-12.
32. Shindo H, Ogura T, Masuno T, Hayashi S, Kishimoto S. Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice. Cancer Immunol Immunother 1985; 20:145-50. (Pubitemid 16256736)